Common use of CLIENT MARKETING AUTHORIZATION Clause in Contracts

CLIENT MARKETING AUTHORIZATION. We are excited to have you as a Square 1 Bank client and want to spread the word about your success! From press releases to mentions on social media sites, and all points in between, Square 1’s marketing and communications team is constantly seeking new opportunities to promote our clients and to connect them to prospects, existing customers, and the larger entrepreneurial/venture capital community. If you complete the authorization below and return it to us, you are authorizing us to reference and/or include your company as part of our marketing and advertising efforts without further review or advance approval by you. Please select all areas that you approve. o All items listed below o List company as a Square 1 Bank customer on social media sites, including Twitter, LinkedIn, Facebook, Square 1 Bank corporate blog, or any other social media site o Press release including your company as a Square 1 Bank client (to include company name and description only; may appear alongside other clients) o Press release including your company as a Square 1 Bank client (general press release not focused on your company, but referring to your company as a client, and including your company’s name, description, and editorial comments; may appear alongside other clients) o Provide quote for inclusion in a Square 1 Bank press release o Use of company name and logo in Square 1 Bank marketing materials including corporate marketing collateral, website, social media sites, and other advertising campaigns o Provide quotes for inclusion in Square 1 Bank marketing materials including corporate marketing collateral, website, social media sites, and other advertising campaigns o Customer case study/application brief (success story to be posted on website, included in press kits and/or pitched to publications as potential articles) o Willing to participate in a video testimonial highlighting your banking relationship and experiences with Square 1 Bank o Other (please describe): If you have questions, please contact your Square 1 banker, or our Marketing + Communications department at xxxxxxxxx@xxxxxx0xxxx.xxx. Please acknowledge your authorization by signing below: Company Name: KALA PHARMACEUTICALS, INC. Authorized Signer: Name: Title: Date: FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT This First Amendment to Loan and Security Agreement (the “Amendment”) is entered into as of October 13, 2016, by and among Pacific Western Bank, a California state chartered bank (as successor in interest by merger to Square 1 Bank) (“Square”), in its capacity as administrative and collateral agent (together with its successors and assigns in such capacity, “Agent”), the Lenders set forth on Schedule 1 of the Agreement (as defined below) or otherwise a party thereto from time to time, including Square 1 in its capacity as a Lender and Alexandria Equities, LLC, a Delaware limited liability company (each individually a “Lender” and, collectively, the “Lenders”), and Kala Pharmaceuticals, Inc. (“Borrower”).

CLIENT MARKETING AUTHORIZATION. We are excited to have you as a Square 1 Bank client and want to spread the word about your success! From press releases to mentions on social media sites, and all points in between, Square 1’s marketing and communications team is constantly seeking new opportunities to promote our clients and to connect them to prospects, existing customers, and the larger entrepreneurial/venture capital community. If you complete the authorization below and return it to us, you are authorizing us to reference and/or include your company as part of our marketing and advertising efforts without further review or advance approval by you. Please select all areas that you approve. o ☐ All items listed below o ☐ List company as a Square 1 Bank customer on social media sites, including Twitter, LinkedIn, Facebook, Square 1 Bank corporate blog, or any other social media site o ☐ Press release including your company as a Square 1 Bank client (to include company name and description only; may appear alongside other clients) o ☐ Press release including your company as a Square 1 Bank client (general press release not focused on your company, but referring to your company as a client, and including your company’s name, description, and editorial comments; may appear alongside other clients) o ☐ Provide quote for inclusion in a Square 1 Bank press release o ☐ Use of company name and logo in Square 1 Bank marketing materials including corporate marketing collateral, website, social media sites, and other advertising campaigns o ☐ Provide quotes for inclusion in Square 1 Bank marketing materials including corporate marketing collateral, website, social media sites, and other advertising campaigns o ☐ Customer case study/application brief (success story to be posted on website, included in press kits and/or pitched to publications as potential articles) o ☐ Willing to participate in a video testimonial highlighting your banking relationship and experiences with Square 1 Bank o ☐ Other (please describe): ______________________________________________________ If you have questions, please contact your Square 1 banker, or our Marketing + Communications department at xxxxxxxxx@xxxxxx0xxxx.xxx. Please acknowledge your authorization by signing below: Company Name: KALA PHARMACEUTICALSVIVEVE, INC. Authorized Signer: /s/ Xxxxx Xxxxxx Name: Xxxxx Xxxxxx Title: CFO Date: FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT This First Amendment to Loan and Security Agreement (the “Amendment”) is entered into as of October 13September 30, 2016, by and among Pacific Western Bank, a California state chartered bank (as successor in interest by merger to Square 1 Bank) (“Square”), in its capacity as administrative and collateral agent (together with its successors and assigns in such capacity, “Agent”), the Lenders set forth on Schedule 1 of the Agreement (as defined below) or otherwise a party thereto from time to time, including Square 1 in its capacity as a Lender and Alexandria Equities, LLC, a Delaware limited liability company (each individually a “Lender” and, collectively, the “Lenders”), and Kala Pharmaceuticals, Inc. (“Borrower”).2014

CLIENT MARKETING AUTHORIZATION. We are excited to have you as a Square 1 Bank client and want to spread the word about your success! From press releases to mentions on social media sites, and all points in between, Square 1’s marketing and communications team is constantly seeking new opportunities to promote our clients and to connect them to prospects, existing customers, and the larger entrepreneurial/venture capital community. If you complete the authorization below and return it to us, you are authorizing us to reference and/or include your company as part of our marketing and advertising efforts without further review or advance approval by you. Please select all areas that you approve. o All items listed below o List company as a Square 1 Bank customer on social media sites, including Twitter, LinkedIn, Facebook, Square 1 Bank corporate blog, or any other social media site o Press release including your company as a Square 1 Bank client (to include company name and description only; may appear alongside other clients) o Press release including your company as a Square 1 Bank client (general press release not focused on your company, but referring to your company as a client, and including your company’s name, description, and editorial comments; may appear alongside other clients) o Provide quote for inclusion in a Square 1 Bank press release o Use of company name and logo in Square 1 Bank marketing materials including corporate marketing collateral, website, social media sites, and other advertising campaigns o Provide quotes for inclusion in Square 1 Bank marketing materials including corporate marketing collateral, website, social media sites, and other advertising campaigns o Customer case study/application brief (success story to be posted on website, included in press kits and/or pitched to publications as potential articles) o Willing to participate in a video testimonial highlighting your banking relationship and experiences with Square 1 Bank o Other (please describe): If you have questions, please contact your Square 1 banker, or our Marketing + Communications department at xxxxxxxxx@xxxxxx0xxxx.xxx. Please acknowledge your authorization by signing below: Company Name: KALA PHARMACEUTICALS, INC. Authorized Signer: Name: Title: Date: FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT This First Amendment to Loan and Security Agreement (the “Amendment”) is entered into as of October 13, 2016, by and among Pacific Western Bank, a California state chartered bank (as successor in interest by merger to Square 1 Bank) (“Square”), in its capacity as administrative and collateral agent (together with its successors and assigns in such capacity, “Agent”), the Lenders set forth on Schedule 1 of the Agreement (as defined below) or otherwise a party thereto from time to time, including Square 1 in its capacity as a Lender and Alexandria Equities, LLC, a Delaware limited liability company (each individually a “Lender” and, collectively, the “Lenders”), and Kala Pharmaceuticals, Inc. (“Borrower”).:

CLIENT MARKETING AUTHORIZATION. We are excited to have you as a Square 1 Bank client and want to spread the word about your success! From press releases to mentions on social media sites, and all points in between, Square 1’s marketing and communications team is constantly seeking new opportunities to promote our clients and to connect them to prospects, existing customers, and the larger entrepreneurial/venture capital community. If you complete the authorization below and return it to us, you are authorizing us to reference and/or include your company as part of our marketing and advertising efforts without further review or advance approval by you. Please select all areas that you approve. o ☐ All items listed below o ☐ List company as a Square 1 Bank customer on social media sites, including Twitter, LinkedIn, Facebook, Square 1 Bank corporate blog, or any other social media site o ☐ Press release including your company as a Square 1 Bank client (to include company name and description only; may appear alongside other clients) o ☐ Press release including your company as a Square 1 Bank client (general press release not focused on your company, but referring to your company as a client, and including your company’s name, description, and editorial comments; may appear alongside other clients) o ☐ Provide quote for inclusion in a Square 1 Bank press release o ☐ Use of company name and logo in Square 1 Bank marketing materials including corporate marketing collateral, website, social media sites, and other advertising campaigns o ☐ Provide quotes for inclusion in Square 1 Bank marketing materials including corporate marketing collateral, website, social media sites, and other advertising campaigns o ☐ Customer case study/application brief (success story to be posted on website, included in press kits and/or pitched to publications as potential articles) o ☐ Willing to participate in a video testimonial highlighting your banking relationship and experiences with Square 1 Bank o ☐ Other (please describe): If you have questions, please contact your Square 1 banker, or our Marketing + Communications department at xxxxxxxxx@xxxxxx0xxxx.xxx. Please acknowledge your authorization by signing below: Company Name: KALA PHARMACEUTICALS, INC. Authorized Signer: Name: Title: Date: FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT This First Amendment to Loan and Security Agreement (the “Amendment”) is entered into as of October 13, 2016, by and among Pacific Western Bank, a California state chartered bank (as successor in interest by merger to Square 1 Bank) (“Square”), in its capacity as administrative and collateral agent (together with its successors and assigns in such capacity, “Agent”), the Lenders set forth on Schedule 1 of the Agreement (as defined below) or otherwise a party thereto from time to time, including Square 1 in its capacity as a Lender and Alexandria Equities, LLC, a Delaware limited liability company (each individually a “Lender” and, collectively, the “Lenders”), and Kala Pharmaceuticals, Inc. (“Borrower”).: